TY - STD TI - Soc Immunother Cancer.http://www.sitcancer.org/, UR - http://www.sitcancer.org/ ID - ref1 ER - TY - JOUR AU - Romero, P. AU - Fox, B. A. PY - 2009 DA - 2009// TI - Announcing the tumor immunology and biological cancer therapy section (edited by iSBTc) of the Journal of Translational Medicine JO - J Transl Med VL - 7 UR - https://doi.org/10.1186/1479-5876-7-80 DO - 10.1186/1479-5876-7-80 ID - Romero2009 ER - TY - JOUR AU - Cheever, M. A. AU - Higano, C. S. PY - 2011 DA - 2011// TI - PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-3126 DO - 10.1158/1078-0432.CCR-10-3126 ID - Cheever2011 ER - TY - JOUR AU - Sharma, P. AU - Wagner, K. AU - Wolchok, J. D. AU - Allison, J. P. PY - 2011 DA - 2011// TI - Novel cancer immunotherapy agents with survival benefit: recent successes and next steps JO - Nat Rev Cancer VL - 11 UR - https://doi.org/10.1038/nrc3153 DO - 10.1038/nrc3153 ID - Sharma2011 ER - TY - STD TI - J Immunother Cancer.http://www.immunotherapyofcancer.org/, UR - http://www.immunotherapyofcancer.org/ ID - ref5 ER - TY - JOUR AU - Wang, E. AU - Monaco, A. AU - MonsurrĂ³, V. AU - Sabatino, M. AU - Pos, Z. AU - Uccellini, L. AU - Wang, J. AU - Worschech, A. AU - Stroncek, D. F. AU - Marincola, F. M. PY - 2009 DA - 2009// TI - Antitumor vaccines, immunotherapy and the immunological constant of rejection JO - IDrugs VL - 12 ID - Wang2009 ER - TY - JOUR AU - Adrian, B. AU - Francesco, C. PY - 2012 DA - 2012// TI - New section in journal of translational medicine: patient-targeted molecular therapies JO - J Transl Med VL - 10 UR - https://doi.org/10.1186/1479-5876-10-92 DO - 10.1186/1479-5876-10-92 ID - Adrian2012 ER - TY - STD TI - J Transl Med.http://www.translational-medicine.com/, UR - http://www.translational-medicine.com/ ID - ref8 ER -